A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study

Abstract Background Studies have suggested the reduced effectiveness of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections with high vancomycin minimum inhibitory concentrations. Alternative agents such as daptomycin may be considered. We conducted a randomi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Shirin Kalimuddin, Yvonne F. Z. Chan, Rachel Phillips, Siew Pei Ong, Sophia Archuleta, David Chien Lye, Thuan Tong Tan, Jenny G. H. Low
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2018-06-01
Schriftenreihe:	Trials
Schlagworte:	Methicillin-resistant Staphylococcus aureus Vancomycin Daptomycin Minimum inhibitory concentration Bacteremia
Online-Zugang:	http://link.springer.com/article/10.1186/s13063-018-2702-8
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!